
A proSpective randomized controlled trial comParing infliximAb-antimetabolites combination therapy to anti-metabolites monotheRapy and infliximab monothErapy in Crohn’s disease patients in sustained steroid-free remission on combination therapy
Investigateurs
- Pr Edouard LOUIS
La fiche complète est accessible aux membres du GETAID.
Se connecter